In addition, a pilot clinical trial using recombinant human angiotensin-converting enzyme 2 in ARDS revealed increased Ang-(1–7) levels but “did not result in improvement in physiological or clinical measures of ARDS in this small study” (Khan et al., 2017). The gene discussed is ACE2; the disease is acute respiratory distress syndrome.